[1] WHO, World Health Organization Global TB Report. 2022.
[2] Steingart KR, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis, 2006; 6, 570−81. doi:  10.1016/S1473-3099(06)70578-3
[3] Otu J, Antonio M, Cheung YB, et al. Comparative evaluation of BACTEC MGIT 960 with BACTEC 9000 MB and LJ for isolation of mycobacteria in the Gambia. J Infect Dev Ctries, 2008; 2, 200−5.
[4] Peng J, Song J, Wang F, et al. Harnessing big data to optimize an algorithm for rapid diagnosis of pulmonary tuberculosis in a real-world setting. Front Cell Infect Microbiol, 2021; 11, 650163. doi:  10.3389/fcimb.2021.650163
[5] Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul), 2015; 78, 47−55. doi:  10.4046/trd.2015.78.2.47
[6] Mechal Y, Benaissa E, El Mrimar N, et al. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis. BMC Infect Dis, 2019; 19, 1069. doi:  10.1186/s12879-019-4687-7
[7] Bhatnagar R, Corcoran JP, Maldonado F, et al. Advanced medical interventions in pleural disease. Eur Respir Rev, 2016; 25, 199−213. doi:  10.1183/16000617.0020-2016
[8] Sun WW, Zhou YM, Yang C, et al. Contrast-enhanced ultrasound guided pleural biopsy improves diagnostic confidence for pleural based lesions: a 3-year prospective study. BMC Pulm Med, 2021; 21, 224. doi:  10.1186/s12890-021-01583-7
[9] Fu Y, Zhang YY, Cui LG, et al. Ultrasound-guided biopsy of pleural-based pulmonary lesions by injection of contrast-enhancing drugs. Front Pharmacol, 2019; 10, 960. doi:  10.3389/fphar.2019.00960
[10] Vadwai V, Boehme C, Nabeta P, et al. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol, 2011; 49, 2540−5.
[11] Marais S, Thwaites G, Schoeman JF, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. Lancet Infect Dis, 2010; 10, 803−12. doi:  10.1016/S1473-3099(10)70138-9
[12] Christopher DJ, Schumacher SG, Michael JS, et al. Performance of Xpert MTB/RIF on pleural tissue for the diagnosis of pleural tuberculosis. Eur Respir J, 2013; 42, 1427−9. doi:  10.1183/09031936.00103213
[13] Sharma M, Agarwal S, Wadhwa N, et al. Spectrum of cytomorphology of tuberculous lymphadenitis and changes during anti-tubercular treatment. Cytopathology, 2007; 18, 180−3.
[14] Elbrolosy AM, El Helbawy RH, Mansour OM, et al. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis. BMC Microbiol, 2021; 21, 144. doi:  10.1186/s12866-021-02210-5
[15] van der Kuyp F, Mahan CS. Prolonged positivity of sputum smears with negative cultures during treatment for pulmonary tuberculosis. Int J Tuberc Lung Dis, 2012; 16, 1663−7. doi:  10.5588/ijtld.12.0238
[16] Pan XF, Yang SF, Deighton MA, et al. A comprehensive evaluation of Xpert MTB/RIF assay with bronchoalveolar lavage fluid as a single test or combined with conventional assays for diagnosis of pulmonary tuberculosis in China: a two-center prospective study. Front Microbiol, 2018; 9, 444. doi:  10.3389/fmicb.2018.00444
[17] Yoo SD, Abebe G, Yoo JE, et al. Diagnostic value of Xpert MTB/RIF assay on pleural tissue obtained via closed pleural biopsy among persons with presumptive tuberculous pleuritis. Afr J Thorac Crit Care Med, 2021; 27, 10. doi:  10.7196/AJTCCM.2021.v27i1.120
[18] Gao S, Wang C, Yu X, et al. Xpert MTB/RIF Ultra enhanced tuberculous pleurisy diagnosis for patients with unexplained exudative pleural effusion who underwent a pleural biopsy via thoracoscopy: a prospective cohort study. Int J Infect Dis, 2021; 106, 370−5. doi:  10.1016/j.ijid.2021.04.011
[19] Koegelenberg CFN, Irusen EM, von Groote-Bidlingmaier F, et al. The utility of ultrasound-guided thoracentesis and pleural biopsy in undiagnosed pleural exudates. Thorax, 2015; 70, 995−7. doi:  10.1136/thoraxjnl-2014-206567
[20] Du JH, Huang ZK, Luo Q, et al. Rapid diagnosis of pleural tuberculosis by Xpert MTB/RIF assay using pleural biopsy and pleural fluid specimens. J Res Med Sci, 2015; 20, 26−31.
[21] Bankar S, Set R, Sharma D, et al. Diagnostic accuracy of Xpert MTB/RIF assay in extrapulmonary tuberculosis. Indian J Med Microbiol, 2018; 36, 357−63. doi:  10.4103/ijmm.IJMM_18_173
[22] Tadesse M, Abebe G, Abdissa K, et al. GeneXpert MTB/RIF assay for the diagnosis of tuberculous lymphadenitis on concentrated fine needle aspirates in high tuberculosis burden settings. PLoS One, 2015; 10, e0137471. doi:  10.1371/journal.pone.0137471
[23] Tomaz A, Raboni S M, Kussen G, et al. The Xpert® MTB/RIF diagnostic test for pulmonary and extrapulmonary tuberculosis in immunocompetent and immunocompromised patients: benefits and experiences over 2 years in different clinical contexts. PLoS One, 2021; 16, e0247185. doi:  10.1371/journal.pone.0247185
[24] Bojang AL, Mendy FS, Tientcheu LD, et al. Comparison of TB-LAMP, GeneXpert MTB/RIF and culture for diagnosis of pulmonary tuberculosis in the Gambia. J Infect, 2016; 72, 332−7. doi:  10.1016/j.jinf.2015.11.011
[25] Dorman SE, Schumacher SG, Alland D, et al. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis, 2018; 18, 76−84. doi:  10.1016/S1473-3099(17)30691-6